Tag: DoE

Navigating Overprocessing Challenges in Transitioning from Lab to Pilot Scale As pharmaceutical companies aim to expedite the transition from laboratory to pilot scale, many encounter challenges related to overprocessing. Overprocessing,…

Strategies to Prevent Overprocessing in Pilot Scale Trials Overprocessing during pilot scale trials is a common issue that can lead to increased costs, longer timelines, and potentially flawed data that…

Addressing Heat Transfer Issues in Pharmaceutical Pilot Scale Batches During the critical transition from lab scale to pilot scale, pharmaceutical manufacturers often encounter significant challenges that threaten product quality and…

Tackling Heat Transfer Issues in Pilot Scale Pharmaceutical Batches In the highly regulated world of pharmaceutical manufacturing, transitioning from lab scale to pilot scale often presents multifaceted challenges. A critical…

Translating Mixing Time from Laboratory to Pilot Scale: A Practical Approach In the pharmaceutical manufacturing process, scaling up from lab to pilot scale presents several challenges, particularly when it comes…

Translating Mixing Times from Lab Scale to Pilot Scale: Addressing Key Challenges In the realm of pharmaceutical manufacturing, the transition from lab scale to pilot scale presents multifaceted challenges. One…

Addressing API Particle Size Risks During the Transition from Lab to Pilot Scale Transitioning from laboratory-scale to pilot-scale manufacturing poses numerous challenges, particularly when it comes to achieving consistent API…

Mitigating API Particle Size Risks When Scaling from Lab to Pilot Scaling from lab to pilot scale presents a variety of challenges, notably the risks associated with active pharmaceutical ingredient…

Checklist for Ensuring Manufacturing Readiness During the Transition from Lab to Pilot Scale The transition from lab scale to pilot scale manufacturing can often be fraught with challenges that may…

Essential Strategies for Navigating Lab to Pilot Scale Challenges in Pharma Manufacturing Transitioning from lab scale to pilot scale is a critical phase in pharmaceutical development. However, this process often…

Building an Effective Control Strategy for Pilot Scale Manufacturing from Development Data As organizations transition from laboratory scale to pilot scale production, they often encounter significant challenges that can affect…

Building an Effective Control Strategy for Transitioning from Lab to Pilot Scale Transitioning from lab-scale to pilot-scale manufacturing often presents significant challenges across various aspects of pharmaceutical production. As organizations…